(1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid

C59H89N17O16S4 — CID 46879931

IUPAC(1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid
SMILESCC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(=O)O)CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCC(=O)N1)C(C)C)C(=O)N2
InChIInChI=1S/C59H89N17O16S4/c1-30(2)19-38-53(85)73-42-26-94-93-25-41(50(82)64-23-46(79)67-39(20-32-11-13-34(77)14-12-32)54(86)68-35(51(83)70-38)9-5-7-17-60)72-57(89)43(74-58(90)48(31(3)4)76-47(80)24-63-49(81)37-15-16-45(78)66-37)27-95-96-28-44(59(91)92)75-52(84)36(10-6-8-18-61)69-55(87)40(71-56(42)88)21-33-22-62-29-65-33/h11-14,22,29-31,35-44,48,77H,5-10,15-21,23-28,60-61H2,1-4H3,(H,62,65)(H,63,81)(H,64,82)(H,66,78)(H,67,79)(H,68,86)(H,69,87)(H,70,83)(H,71,88)(H,72,89)(H,73,85)(H,74,90)(H,75,84)(H,76,80)(H,91,92)/t35-,36+,37-,38-,39-,40-,41-,42-,43-,44-,48-/m0/s1
InChIKeyJQMZORXHAOQOMZ-HVHKLXTMSA-N
MW1420.73 g/mol
LogP-3.91
Rot. Bonds22

About (1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid

(1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid (PubChem CID 46879931) has the molecular formula C59H89N17O16S4 and a molecular weight of 1420.73 g/mol. Its IUPAC name is (1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid.

Molecular Properties

Compound Name(1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid
PubChem CID46879931
Molecular FormulaC59H89N17O16S4
Molecular Weight1420.73 g/mol
Exact Mass1419.56
IUPAC Name(1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid
SMILESCC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(=O)O)CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCC(=O)N1)C(C)C)C(=O)N2
InChIInChI=1S/C59H89N17O16S4/c1-30(2)19-38-53(85)73-42-26-94-93-25-41(50(82)64-23-46(79)67-39(20-32-11-13-34(77)14-12-32)54(86)68-35(51(83)70-38)9-5-7-17-60)72-57(89)43(74-58(90)48(31(3)4)76-47(80)24-63-49(81)37-15-16-45(78)66-37)27-95-96-28-44(59(91)92)75-52(84)36(10-6-8-18-61)69-55(87)40(71-56(42)88)21-33-22-62-29-65-33/h11-14,22,29-31,35-44,48,77H,5-10,15-21,23-28,60-61H2,1-4H3,(H,62,65)(H,63,81)(H,64,82)(H,66,78)(H,67,79)(H,68,86)(H,69,87)(H,70,83)(H,71,88)(H,72,89)(H,73,85)(H,74,90)(H,75,84)(H,76,80)(H,91,92)/t35-,36+,37-,38-,39-,40-,41-,42-,43-,44-,48-/m0/s1
InChIKeyJQMZORXHAOQOMZ-HVHKLXTMSA-N
XLogP-3.91
TPSA516.55 Ų
H-Bond Donors18
H-Bond Acceptors22
Rotatable Bonds22
Heavy Atoms96
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001420.73
LogP ≤ 5-3.91
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'disulphide', 'substructure': 'N/A'}

Analyze (1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid?
The IUPAC name of (1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid (CID 46879931) is (1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid.
What is the SMILES notation for (1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid?
The canonical SMILES for (1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid is CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(=O)O)CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCC(=O)N1)C(C)C)C(=O)N2.
What is the InChIKey of (1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid?
The InChIKey is JQMZORXHAOQOMZ-HVHKLXTMSA-N. The full InChI is InChI=1S/C59H89N17O16S4/c1-30(2)19-38-53(85)73-42-26-94-93-25-41(50(82)64-23-46(79)67-39(20-32-11-13-34(77)14-12-32)54(86)68-35(51(83)70-38)9-5-7-17-60)72-57(89)43(74-58(90)48(31(3)4)76-47(80)24-63-49(81)37-15-16-45(78)66-37)27-95-96-28-44(59(91)92)75-52(84)36(10-6-8-18-61)69-55(87)40(71-56(42)88)21-33-22-62-29-65-33/h11-14,22,29-31,35-44,48,77H,5-10,15-21,23-28,60-61H2,1-4H3,(H,62,65)(H,63,81)(H,64,82)(H,66,78)(H,67,79)(H,68,86)(H,69,87)(H,70,83)(H,71,88)(H,72,89)(H,73,85)(H,74,90)(H,75,84)(H,76,80)(H,91,92)/t35-,36+,37-,38-,39-,40-,41-,42-,43-,44-,48-/m0/s1.
What are the key properties of (1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid?
(1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid has a molecular weight of 1420.73 g/mol, XLogP of -3.91, 22 rotatable bonds, 18 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,4R,9R,12R,15S,18R,21S,24S,27S)-12,24-bis(4-aminobutyl)-27-[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-4-[[(2S)-3-methyl-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]butanoyl]amino]-21-(2-methylpropyl)-3,11,14,17,20,23,26,29,32-nonaoxo-6,7,34,35-tetrathia-2,10,13,16,19,22,25,28,31-nonazabicyclo[16.14.4]hexatriacontane-9-carboxylic acid is sourced from PubChem (CID 46879931), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).